Identification of miRNA-mRNA-TF regulatory networks in peripheral blood mononuclear cells of type 1 diabetes
- PMID: 35534828
- PMCID: PMC9087960
- DOI: 10.1186/s12902-022-01038-y
Identification of miRNA-mRNA-TF regulatory networks in peripheral blood mononuclear cells of type 1 diabetes
Abstract
Background: Type 1 diabetes (T1D) is a T lymphocyte-mediated and B lymphocyte-assisted autoimmune disease. We aimed to identify abnormally expressed genes in peripheral blood mononuclear cells (PBMCs) of T1D and explore their possible molecular regulatory network.
Methods: Expression datasets were downloaded from the Gene Expression Omnibus (GEO) database. Then, the differentially expressed genes (DEGs) and differentially expressed miRNAs (DEmiRNAs) were identified, and functional enrichment and immune cell infiltration analysis were performed. The starBase, miRTarBase, TarBase, JASPAR, ENCODE, and TRRUST databases constructed the miRNA-mRNA-TF regulatory network. The ROC curves were plotted to evaluate the sensitivity and specificity of miRNAs and mRNAs.
Result: A total of 216 DEGs directly or indirectly related to type I diabetes mellitus, natural killer cell-mediated cytotoxicity, Th1, and Th2 cell differentiation, and the IL-17 and TNF signaling pathways were obtained. The miRNA-mRNA-TF network indicates that miR-320a and SOX5 are the only miRNAs and TFs that both target ADM and RRAGD. The ROC curves showed that ADM (0.9375), RRAGD (0.8958), and hsa-mir-320a (0.9417) had high accuracy in T1D diagnosis.
Conclusion: The constructed regulatory networks, including miR-320a/ADM/SOX5 and miR-320a/RRAGD/SOX5, may provide new insight into the mechanisms of development and progression in T1D.
Keywords: Differentially expressed genes (DEGs); MicroRNAs; Regulatory networks; Transcription factors (TFs); Type 1 diabetes (T1D).
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures





Similar articles
-
Circulating hsa-miR-320a and its regulatory network in type 1 diabetes mellitus.Front Immunol. 2024 Oct 11;15:1376416. doi: 10.3389/fimmu.2024.1376416. eCollection 2024. Front Immunol. 2024. PMID: 39464889 Free PMC article.
-
Competing endogenous RNA network analysis explores the key lncRNAs, miRNAs, and mRNAs in type 1 diabetes.BMC Med Genomics. 2021 Feb 1;14(1):35. doi: 10.1186/s12920-021-00877-3. BMC Med Genomics. 2021. PMID: 33526014 Free PMC article.
-
Construction of miRNA-mRNA-TF Regulatory Network for Diagnosis of Gastric Cancer.Biomed Res Int. 2021 Nov 18;2021:9121478. doi: 10.1155/2021/9121478. eCollection 2021. Biomed Res Int. 2021. PMID: 34840985 Free PMC article.
-
Identification of key regulatory genes and their working mechanisms in type 1 diabetes.BMC Med Genomics. 2023 Jan 17;16(1):8. doi: 10.1186/s12920-023-01432-y. BMC Med Genomics. 2023. PMID: 36650594 Free PMC article.
-
Recent advances in early diagnosis and treatment of T1D with miRNAs.Front Endocrinol (Lausanne). 2025 May 15;16:1582963. doi: 10.3389/fendo.2025.1582963. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40444240 Free PMC article. Review.
Cited by
-
MiR-192-5p targets cell cycle regulation in diabetic kidney disease via cyclin-dependent kinase inhibitor 3.Noncoding RNA Res. 2024 Nov 19;11:60-72. doi: 10.1016/j.ncrna.2024.11.003. eCollection 2025 Apr. Noncoding RNA Res. 2024. PMID: 39736853 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous